Clinical outcomes of hepatocellular carcinoma patients after hepatectomy treated with TACE in combination with sorafenib: a propensity score matched analysis

被引:0
|
作者
Li, Yujie [1 ]
Zhao, Ruichen [2 ]
Li, Xiao [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Intervent Therapy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Univ Chinese Acad Sci, Beijing, Peoples R China
关键词
Hepatocellular carcinoma (HCC); recurrent; sorafenib; transarterial chemoembolization (TACE); RECURRENCE; RESECTION; CHEMOEMBOLIZATION; PATTERNS; ANGIOGENESIS; MULTICENTER; CANCER;
D O I
10.21037/tcr-22-2784
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To assess the long-term effects of transarterial chemoembolization (TACE) combined with sorafenib versus TACE alone procedures in recurrent patients with unresectable hepatocellular carcinoma (HCC). Methods: A total of 381 recurrent patients treated with partial hepatectomy undergoing either TACE + sorafenib treatment or TACE alone were included in this retrospective research. To minimize bias brought on by confounding factors, propensity score matching (PSM) was used. The clinical effectiveness, complications, and negative responses of two groups were noted. Overall survival (OS) was the main result. The secondary outcome was time to target tumor progression (TTTP). The risk variables for OS were investigated using the Cox proportional hazards model. Results: There were 32 individuals in each group following PSM. According to mRECIST (modified response evaluation criteria in solid tumors), patients receiving TACE + sorafenib had a significantly longer TTTP compared to patients receiving sorafenib alone (P=0.017). The median OS was 48.5 months with TACE plus sorafenib and 41.0 months with TACE alone. At 5 years, however, survival was comparable between groups (P=0.300). In the combination group, the most frequent side effect was hand-foot skin reaction (81.3%), whereas, in the monotherapy group, the most frequent side effect was fatigue (71.9%). In neither group were there any treatment-related fatalities. Conclusions: Although TACE plus sorafenib did not significantly lengthen OS compared to TACE alone, it did considerably enhance TTTP.
引用
收藏
页码:1088 / 1099
页数:12
相关论文
共 50 条
  • [1] Prognostic analysis and limited efficacy of adjuvant TACE in hepatocellular carcinoma following hepatectomy: a propensity score-matched study
    Peng, Yi
    Shen, Shuang
    Feng, Yifei
    Wen, Zhaochan
    Qin, Jiayin
    Lu, Wei
    Xiang, Bangde
    LANGENBECKS ARCHIVES OF SURGERY, 2025, 410 (01)
  • [2] Comparison of the prognosis of BCLC stage A ruptured hepatocellular carcinoma patients after undergoing transarterial chemoembolization (TACE) or hepatectomy: a propensity score-matched landmark analysis
    Xia, Feng
    Zhang, Qiao
    Chen, Xiaoping
    Zhang, Bixiang
    Ndhlovu, Elijah
    Zhang, Mingyu
    Zhu, Peng
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2022, 36 (12): : 8992 - 9000
  • [3] Comparison of the prognosis of BCLC stage A ruptured hepatocellular carcinoma patients after undergoing transarterial chemoembolization (TACE) or hepatectomy: a propensity score-matched landmark analysis
    Feng Xia
    Qiao Zhang
    Xiaoping Chen
    Bixiang Zhang
    Elijah Ndhlovu
    Mingyu Zhang
    Peng Zhu
    Surgical Endoscopy, 2022, 36 : 8992 - 9000
  • [4] Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis
    Hong-wei Xu
    Fei Liu
    Hong-yu Li
    Yong-gang Wei
    Bo Li
    Surgical Endoscopy, 2018, 32 : 712 - 719
  • [5] Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis
    Xu, Hong-wei
    Liu, Fei
    Li, Hong-yu
    Wei, Yong-gang
    Li, Bo
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (02): : 712 - 719
  • [6] Pure laparoscopic vs open right hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis
    Nam, Yi-Yeon
    Hong, Suk Kyun
    Hong, Su Young
    Lee, Sola
    Choi, YoungRok
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (03) : 293 - 302
  • [7] Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis A Propensity Score Matched Analysis
    Yoon, Young-In
    Kim, Ki-Hun
    Kang, Sung-Hwa
    Kim, Wan-Joon
    Shin, Min-Ho
    Lee, Sang-Kyung
    Jung, Dong-Hwan
    Park, Gil-Chun
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Ha, Tae-Yong
    Song, Gi-Won
    Hwang, Shin
    Lee, Sung-Gyu
    ANNALS OF SURGERY, 2017, 265 (05) : 856 - 863
  • [8] Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis
    Chen, Jinbin
    Lu, Shixun
    Zhang, Yaojun
    Xu, Li
    Chen, Jiancong
    Wang, Juncheng
    Chen, Minshan
    Zhang, Rongxin
    Zhou, Zhongguo
    JOURNAL OF CANCER, 2018, 9 (10): : 1745 - 1753
  • [9] Thrombocytopenia predicts the prognosis of hepatocellular carcinoma patients with Ishak score 6 after hepatectomy: A propensity score matching analysis
    Zhang, Jinfu
    Wang, Tao
    Xu, Liangliang
    Xu, Mingqing
    ASIAN JOURNAL OF SURGERY, 2021, 44 (01) : 423 - 424
  • [10] Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis
    Tatsuya Orimo
    Toshiya Kamiyama
    Kenji Wakayama
    Shingo Shimada
    Akihisa Nagatsu
    Yoh Asahi
    Yuzuru Sakamoto
    Hirofumi Kamachi
    Akinobu Taketomi
    Annals of Surgical Oncology, 2020, 27 : 4153 - 4163